➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
Mallinckrodt
Moodys
Colorcon

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

QUININE SULFATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Quinine Sulfate

A generic version of QUININE SULFATE was approved as quinine sulfate by TEVA PHARMS on September 28th, 2012.

  Start Trial

Drug patent expirations by year for QUININE SULFATE
Drug Prices for QUININE SULFATE

See drug prices for QUININE SULFATE

Recent Clinical Trials for QUININE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidade do PortoPhase 2
University of PennsylvaniaPhase 1/Phase 2
Cetero Research, San AntonioPhase 1

See all QUININE SULFATE clinical trials

Pharmacology for QUININE SULFATE
Drug ClassAntimalarial
Medical Subject Heading (MeSH) Categories for QUININE SULFATE

US Patents and Regulatory Information for QUININE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms QUININE SULFATE quinine sulfate CAPSULE;ORAL 203729-001 Jul 15, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Novast Labs QUININE SULFATE quinine sulfate CAPSULE;ORAL 204372-001 Jul 22, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Ltd QUININE SULFATE quinine sulfate CAPSULE;ORAL 203112-001 Apr 24, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim
Colorcon
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.